@mercidabbik@gkfkfkfkfjdj @keditaparmisasu @1Masal1Kivanc @_Ezmelek Git DNA testi yaptirda bakalim ne kadar Turksun? Gerci o zamanda ben DNA ile degil ruhen kalben Turkum diyeceksin. Git Azerbaycana,Ozbekistana Tajikistana Turkmenistana amina kodugumun kuduzu. Oradan kiz alda biraz DNAan tetiklensin
@HeyDouglas7 Adam ismini değiştiriyor, Ki ailesi de zaten biz Türk oğlu Türküz diyordur. Daha ne yapsın Redur? @milliyetcikavga lütfen bir yol göster bu Kürt olmayı reddedip ben Türküm diyenlere. Ne yapmalılar. Lütfen yardımcı olurmusunuz. Teşekkürler
@fed_khandelwal@jeromeleonard5@bioinvestor24 unlike other inhibitors, TNG462 activity doesn’t drop in high-SAM conditions. That’s what gives it both selectivity and potency and what the graph shows. Meaning of you have a MTAP deleted disease that is homozygous you should pursue this drug rather than anything else.
@jeromeleonard5@bioinvestor24 Challenge has always been potency vs. selectivity. TNG462 avoids the potency loss seen with other PRMT5i under high-SAM conditions.Maintaining strong binding in both hi-SAM and hi-MTA, it sustains potency while preserving MTAP-dependent selectivity.
@jeromeleonard5@bioinvestor24 TNG462 is SAM-competitive in mechanism, but this graph shows that it avoids the main drawback of earlier inhibitors: loss of potency in high-SAM. It binds tightly to PRMT5 in both hi-SAM and hi-MTA conditions, making it highly effective in MTAP-deleted tumors.
They don't want you to know this but you can enroll at ASU for $20 and get a student discount to everything across America.
We got a brand new Samsung fridge for $1200
@pixel8foto Taqqiya,signifies the act of concealing one's true beliefs or intentions to avoid harm or persecution. Don't ever trust these MFs for one second.